This study focused on the subacute renal lesions resulting from the infusion of stroma free hemoglobin (SFH), which remains under evaluation as a potential blood substitute despite limited renal toxicity observed in acute infusion. Four groups of rats received different doses of SFH (0.03, 0.48, 0.96, and 1.46 g, respectively) and were monitored, on alternate days, for their glomerular filtration rate over the course of 10 days. Another group of 6 rats receiving 0.96 g SFH was sacrificed at day 10 for examination of renal morphology. The low dose (0.03 g) of SFH infusion did not alter the creatinine clearance (Clcr) over 10 days. The Clcr decreased in rats receiving 0.48 g SFH but fully recovered at day 10. A persistent decrease in Clcr was observed in the groups of rats receiving 0.96 and 1.68 g of SFH. Tubular necrosis was the most prominent renal lesion distributed in the proximal tubules, especially in the convoluted segment of the juxtamedullary nephrons. Pearls' stained cytoplasmic granules and electron-dense lysosomal granules were found in surviving proximal tubules. Necrosis was the predominant mechanism of cell death. This study revealed for the first time proliferation of smooth endoplasmic reticulum in the proximal tubules after SFH treatment, where it appeared as nodular aggregates of tubulovesicular structures. The effect of SFH on the proximal tubule appeared to be a direct toxicity, and this toxicity was shown to be dose dependent. The presence of reversible toxicity indicated that a safety limit dosage for SFH infusion exists and that tolerance dose of SFH can be determined for clinical applications.
INTRODUCTION
For nearly a century, hemoglobin solution has been studied for its potential application as a blood substitute. Early efforts were hampered by its toxicity, which was associated with contaminants such as cell membrane phospholipids. However, toxic stromal components can be removed by ultrafiltration to produce stroma free hemoglobin (SFH) (24) . Such SFH has shown reduced toxicity, good tolerance in experimental animals, and promising results in phase I and II clinical trials (4, (9) (10) (11) 29 ).
In addition, a reduction of renal filtration rate and a blunting of natriuresis after infusion of SFH in rats have also been reported (1, 25, 32) . Infused SFH has a short halflife because of its dissociation from tetramers into dimers, which are subsequently excreted through glomerular filtration. Therefore, various means of cross-linkage and polymerization were employed to produce more stable and larger molecules (12, 22) . Such modified hemoglobin solutions had shown reduced nephrotoxicity and longer retention in the circulation and had thus been used on various animals during various clinical trials. Modified hemoglobin also abolished the vasoconstrictive effects of native SFH via an interaction with nitric oxide metabolism (1, 26) .
Eldridge et al showed that following induced hemorrhagic shock, dogs were successfully resuscitated with the use of both SFH and pyridoxalated hemoglobin (7) . Applications other than volume resuscitation, such as treatment of endotoxemic shock and sickle-cell crisis, were also reported in both animal models and humans (11, 2) . However, these modified hemoglobins were also excreted in urine, though to a lesser extent than was the unmodified SFH, and as much as 44% of infused pseudocross-linked tetramer hemoglobin was recovered from urine (28) .
The literature has shown conflicting results with respect to the nephrotoxicity of unmodified SFH, which can partly be explained by the experimental time frames, which are typically limited to a few hours to 2 days (25, 26, 29) . Studies employing such experimental time frames will be unable to identify those cases of renal failure occurring in a subacute course after the nephrotoxic insult. Both experiments using the acute model, as reported by Urbaitis et al and Thompson et al, showed a stable glomerular filtration rate (GFR) in euvolemic and hypovolemic rats, which were infused with SFH at doses of up to 0.3 g (26, 29) . However, in another study, Abassi et al observed a decrease in GFR within 3 hours after administration of a much lower dose of 0.08 g SFH (1).
The reason for this discrepancy was not apparent from their experimental design. Tam and Wong showed a decrease in GFR together with tubular enzymuria, which occurred within 5 hours after infusion of 0.8 g (-2.5 g/ kg) SFH in euvolemic rats (25) . Furthermore, proximal tubular necrosis and distal heme cast formation at 24 hours after SFH infusion has been reported (23, 32) . These results indicate that a moderate degree of renal toxicity can be induced by SFH. Different mechanisms, such as renal hypoperfusion or ischemia, cast formation in distal tubules, and direct proximal tubule damage, have been suggested in nephrotoxicity induced by SFH (31) . Proximal tubule enzymuria has been demonstrated after SFH-induced renal failure, thus indicating that a proximal tubular lesion occurred after SFH infusion (25) . In addition, enzyme induction, such as tubular heme oxygenase, was found after rhabdomyolysis, and this enzyme induction protected the kidney from subsequent damage (18) . As a result, a reparative phase may be induced after renal failure as a result of SFH and myoglobin, but this possibility has not been studied in detail. Previous studies of SFH nephrotoxicity have mostly concentrated on functional disturbances and morphology within short time intervals (mostly up to 48 hours) following renal failure. This short duration of study may cause researchers to miss the recovery phase of SFH-induced renal pathology. The following is a report of our investigation of the subacute renal response to a single-dose SFH injection in rats.
METHODS
SFH was prepared from hemolysate of outdated human whole blood, which was purified (by 0.22 )JLm filtration) to remove stromal components, as previously described (25) .
Twenty-four Sprague-Dawley male rats, each weighing between 350 and 400 g, were divided into 4 groups for the functional study. These rats were maintained in metabolic cages for the duration of the experiment period of 12 days and were fed an unrestricted diet of dried pellets and water. Each group of 6 rats received a 9.6% SFH infusion, and groups 1, 2, 3, and 4 received a sham infusion of 0.03 g (-0.08 g SFH/kg), 0.48 g (-1.3 g/kg), 0.96 g (-2.5 g/kg), or 1.68 g (-4.5 g/kg) of SFH, respectively. The infusion of SFH was accomplished over a 1-hour period, during which the rat was under etherinduced anesthesia.
On experiment day 1, blood was collected from each rat to determine a baseline creatinine clearance (Clcr).
Following SFH infusion on day 2, blood was sampled every 2 days throughout the study, and these samples were paired with 24-hour urine collection. Hemoglobin excretion in urine collected during the 1-hour infusion period was quantitated using the method described by Drabkin and Austin (6) . Plasma or urine electrolytes and creatinine were measured by ion-selective electrodes and Jaffe reaction.
For morphology study, a separate group of 6 rats was infused with 0.96 g SFH (-2.5 g /kg), the lowest dose that induces a persistent filtration failure; kidney tissue was collected 10 days after SFH infusion. The rats were anesthetized with 20 mg/kg phenobarbital for the tissue harvest. The abdomen was opened, and the kidneys were perfused with 70 to 100 ml of 2% glutaraldehyde in phosphate buffer, at 120 cm H20 pressure, for 3 to 5 minutes. The renal cortex and medulla sampled were stored overnight in the same fixative and were then stored in 1 % osmium tetroxide. Semithin and ultrathin sections were prepared by standard technique. Six sham-infused rats were used as controls. The other kidney was examined with light microscopy with hematoxylin and eosin, periodic acid-silver methenamine, and Pearls' stains for hemosiderin pigment.
RESULTS
All of the study rats showed a comparable baseline GFR, as measured by daily endogenous Clcr. In group 1, there was no change in Clcr over the course of the 10 days (Figure 1 a) . A transient decrease in Clcr was found in group 2, with the lowest Clcr reaching 65°~0 of the pre-SFH level at day 4. The Clcr gradually recovered and returned to baseline level at day 8. However, in both groups 3 and 4, a persistent decline of Clcr was observed, with no sign of recovery by day 10 . A dose-dependent urine hemoglobin excretion was found (Figure lb ). On average, 3% of the infused SFH was excreted during the first hour, and rats receiving higher doses demonstrated a higher percentage of excretion.
Under light microscopy, focal tubular necrosis was apparent in rats receiving 0.96 g SFH. Intraluminal cellular debris was found in the proximal tubules, indicating that there was a proximal distribution of necrosis (Figure 2 ). Only a few tubular casts were found in the distal nephrons. The glomeruli were unremarkable. The Pearls' stain demonstrated heavy positive cytoplasmic granules in proximal tubules, especially those in the cortical labyrinth, but an absence of staining in the medullary and distal convoluted tubules.
Under electron microscopy, the necrotic lesions were largely confined to the proximal tubules. Cellular necrosis was especially prominent in the convoluted segments of the proximal tubules, but it was also found in the straight segment (Figure 3 ). The glomeruli were well preserved. Other than a few cast-containing distal tubules, the rest of the nephron was unremarkable. The proximal tubule showed both scattered and confluent cell necrosis. Electron-dense granules were found inside secondary lysosomes in the surviving proximal tubular cells (Figure 4 ). This feature was more frequently observed in the S 1 segments and was less common in straight segments of the proximal tubules. The apical phagocytic apparatus in the proximal tubules was intact.
As observed in other studies of SFH-induced renal failure in the acute phase, there were Pearls'-stained cytoplasmic granules in the proximal tubules. They appeared as electron-dense lysosomal granules at ultrastructures (9) . These materials represented hemosiderin or the residual iron-containing product of endocytosed hemoglobin (Figure 4 ). FIGURE l.-a) Changes of creatinine clearance (Clcr) during the experimental period. SFH was infused on day 2 after baseline Clcr was determined. Four groups of 6 rats each were given specified amounts of SFH according to the dosage described in the figure. b) Urine excretion of hemoglobin during the 1-hour infusion period. A dose-related urinary excretion of hemoglobin was observed. The maximum rate of hemoglobin excretion is represented by this 1-hour period.
A profound smooth endoplasmic reticulum (sER) proliferation was seen in the S3 segment of the proximal tubule. The sER formed nodular aggregates of tubulovesicular structures, mostly located along the lateral and basal cytoplasmic membrane, and these aggregates were occasionally present in the center of the cytosol ( Figures   5 and 6 ). Those present in the basolateral part of the cytoplasm were larger in size than those found in the more central portion of the cytoplasm. This phenomenon was not observed in other segments of the proximal tubule. 
DISCUSSION
This study describes the subacute renal lesions resulting from an euvolemic infusion of SFH in rats monitored every other day for 10 days. The results revealed a dosedependent nephrotoxicity of unmodified SFH. A sham infusion of SFH did not lead to an impairment of GFR, but when the dose was increased to 0.48 g SFH, reversible acute renal failure (ARF) resulted, and a further increase in dose of SFH led to nonrecoverable renal failure.
The reversible filtration failure resulting from infusion of 0.48 g SFH indicates a possible regenerative potential in kidneys following SFH-induced nephrotoxicity. However, chronic renal failure would result when the injury exceeded the limit of repair, as was observed in rats receiving 0.96 and 1.68 g SFH. The existence of such an upper safety limit for SFH infusion was also reported in another study (23) . The doses of SFH in this study ranged from 0.03 to 1.68 g, and they were chosen to be comparable to dosages studied previously. For evaluation of morphologic lesions, it was only logical to examine the group of rats determined by the minimal dose of SFH (0.96 g) that was required to induce a sustained renal failure.
The morphologic findings were in keeping with a direct nephrotoxic effect of SFH on the proximal tubules, and they also indicated the presence of a reparative mechanism. Both light microscopy and ultrastructures demonstrated the proximal distribution of acute tubular necrosis and indicated that necrotic cell death, rather than apoptosis, was the major lethal pathway in renal epithelium exposed to SFH. The proliferation of sER in the S3 segment of the proximal tubule has not been reported in previous studies on SFH. However, such a feature has been observed in animals following repeated injection of phenobarbital, chlorinated hydrocarbon, and cytotoxic drugs such as vinblastine (5, 8, 21, 27) . Some of these compounds are characterized as inducers of the microsomal mixed-function oxidase system (provided with a system of enzymes), which mediates redox reactions. Induction of heme oxygenase activity was also found after hemoglobin injection and induced rhabdomyolysis (20) . Following enzyme induction, experimental animals were FIGURE 5.-a) This proximal tubule epithelium of S3 segment shows features of sER proliferation and multiple aggregation of tubulovesicular structures distributed along the basolateral membrane (arrowhead). Lysosomes are largely free of electron-dense granules in this segment. X 12,000. b) S3 proximal tubule of control rat is shown for comparison of the degree of sER proliferation found in SFH-infused rats, as shown in Figure 5a . X 15,000. protected from subsequent renal insult (18) . It is likely that sER proliferation is the morphological expression of an induction of microsomal enzymes, thus representing the reparative mechanism in the proximal tubules.
The subacute morphologic lesions observed in this study enhance our understanding of the mechanism of hemoglobin-induced ARE Although renal vasoconstriction and hypoperfusion are generally regarded to be the major cause of tubular necrosis, the findings in this study do not support such a mechanism, since lesions induced by ischemia or hypoperfusion are typically located along the thick ascending limb (3, 13) . Moreover, apoptosis, which is a prominent feature in hypoxic renal injury, is not apparent or absent in SFH-induced ARF (3, 15) . In fact, the thick ascending limb of the rats was well preserved in our study. Furthermore, ATP depletion, a hallmark of renal ischemia, was not detected in the kidney after SFH-induced ARF (23) . The distal tubular casts with subsequent tubular blockage and dilatation, which were prominent features shortly after SFH infusion, have been the proposed mechanism to explain the SFH-induced renal failure (14, 32) . However, distal tubular casts were infrequently seen 10 days after SFH infusion, though the filtration failure persisted. Such an observation indicates that tubular blockage, which may be significant during the acute phase of SFH-induced ARF, was largely resolved after 10 days. A sustained proximal tubular injury induced after SFH infusion may account for the persistent filtration failure. The persistent proximal tubular cell necrosis, which appears long after clearance of hemoglobin from the circulation, supports such a notion.
There are a few hypotheses that may account for the toxic mechanism of SFH on the tubular epithelium. Uptake of a large amount of hemoglobin from the filtrate might overload the endocytosis machinery and lead to cell injury. However, in the present study, we did not observe any changes in the apical phagocytic apparatus. In addition, although the hemoglobin-containing endosomes were shown by Somers et al to be functionally intact, the cytoplasmic accumulation of iron-containing hemoglobin degradation products may cause cellular damage through the production of free radicals (16, 19, 23, 30) . Both iron-chelating agents, such as desferoxamine, and free-radical scavengers were shown to alleviate SFH-induced ARF (17, 19) .
In summary, this study shows that persistent proximal tubular necrosis represented the predominant lesion during the subacute phase of SFH-induced ARF The filtration failure persisted despite the rapid clearance of SFH from the circulation. We also demonstrated a dose-dependent nephrotoxicity of SFH in rats, and this observation also indicates that a safe upper-limit dose for administration of SFH does indeed exist. The proliferation of sER indicates the presence of a reparative process. Intracellular accumulation of iron-containing residues af- ter degradation of endocytosed hemoglobin may be directly toxic to the proximal tubular epithelium. The potential to induce ARF calls for more studies on the renal effects of SFH and its modified blood substitutes. Application of these products in humans requires close monitoring of the glomerular filtration and tubular functions.
